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Why ROI?
Do outcomes achieved by public health
interventions justify their costs?
Where should new investments be directed
to achieve their greatest impact?

Related questions of value…
• How much health can we produce through
public health investments?
• Can public health investments help “bend the
curve” to contain medical costs?

ROI Uncertainty and Controversy

Public health spending and medical costs

per case

Roehrig et al. Health Affairs 2011

Challenges in demonstrating ROI
in public health
Time lag between costs and benefits
Distribution of costs and benefits:
concentrated costs but diffuse benefits
Measurement of costs and benefits requires
good information systems
• Attribution of benefits: the counterfactual

ROI Key Ingredients
Investments
Costs of implementing public health interventions
Who’s investments?

Returns
Valuation of the outputs and outcomes attributable
to public health interventions
Who realizes returns?
Over what time frames?
Compared to what?

Managing ROI Expectations
Cost savings – a high bar
Cost effectiveness – value for dollars spent
– Compared to status quo
– Compared to other possible investments
– Compared to doing nothing
…Key concept: opportunity costs

Estimating ROI in public health:
Key Considerations
Perspective
Federal, state, health system, or societal?
Time Horizon
How long can you wait to realize returns?
Types of Interventions
Primary, secondary or tertiary prevention
Cross-cutting infrastructure

Estimating ROI in public health:
Key Considerations - Costs
Direct costs
Cost of implementing intervention/infrastructure
Cost savings attributable to the intervention
Indirect costs
Economic value of productivity gains/losses or time
savings/costs attributable to the intervention

Estimating ROI in public health:
Key Considerations - Benefits
Efficiency gains (captured in cost measures)
Reduced labor costs
Reduced material costs
Productivity gains (captured in output measures)
Services delivered
Cases detected
Revenue gains (captured in financial measures)
Health gains (captured in outcome measures)
Deaths averted
Cases prevented
Quality-adjusted life years gained

Estimating ROI in public health:
Key Considerations
Break even
How long does it take to recoup investment?
Maintenance/Persistence
How long do the benefits last?
Recurring costs?

Achieving ROI in public health:
Key Considerations
Economies of scale: many public health
interventions can be delivered more efficiently
across larger populations
Economies of scope: efficiencies can be realized by
using the same infrastructure to deliver an array of
related programs and services

Estimating ROI in public health:
Types of Analyses
Macro-level analysis
Infrastructure-level analysis
Intervention-level analysis
Process-level analysis

Estimating ROI in public health:
Macro-level Analysis

Source: Trust for America’s Health, 2009

Estimating ROI in public health:
Intervention-level Analysis
• Smoking cessation interventions cost an estimated
$2,587 for each life-year gained
• $1 spent on STD and pregnancy prevention
produces $2.65 in medical cost savings
• $1 spent on preconception care for diabetic women
produces $5.19 in medical cost savings
• $1 spent on childhood
immunization produces
$6.30 in medical cost savings

Source: Centers for Disease Control and Prevention 2008
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Injury

Medical Care Offsets Attributable to
Local Public Health Spending, 1993-2008
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Projected effects of new
ACA public health spending
• 1.2% increase in public health spending in
average community over 10 years:
Public health cost
$7.2M
Medical cost offset -$6.3M (Medicare only)
Deaths averted
175.8
Life years gained
1758
Net cost/LY
$546

Mays et al. forthcoming 2012

Preventable disease burden
and national health spending

>75% of national health spending is attributable
to chronic diseases that are largely preventable
– 80% of cardiovascular disease
– 80% of diabetes
– 60% of lung diseases
– 40% of cancers
(not counting injuries, vaccine-preventable diseases)

<3% of national health spending is allocated to
public health and prevention
CDC 2011

Public health’s share of national health spending
$Billions

USDHHS National Health Expenditure Accounts
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Public Health in the Affordable Care Act


Public Health & Prevention Fund: $15 billion in
new federal public health spending over 10
years (cut by $5B this year)



Incentives for hospitals, health insurers,
employers to invest in public health and
prevention

Implications for Policy and Practice


Mortality reductions achievable through
increases in public health spending may equal or
exceed the reductions produced by similar
expansions in local medical care resources



Increased public health investments help to
reduce geographic disparities in population
health and bend the medical cost curve



Gains from increased federal investments may
be offset by reductions in state and local
spending

Advancing ROI Analysis
in Public Health


Enhanced tracking of public health expenditures



Enhanced monitoring of program performance
–
–
–
–



Reach/targeting
Effectiveness
Efficiency
Equity

Analysis of cross-cutting infrastructure needed to
implement/maintain programs
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